August 24, 2026StocksTechnology·Bullish·fda regulatory
FDA clears Roche and Eli Lilly's Alzheimer's blood test
The FDA cleared a blood test for identifying Alzheimer's disease symptoms, developed jointly by Roche and Eli Lilly. The clearance was reported by multiple independent sources on August 24, 2026.
Detected & updated continuously · Source: Nebula
Story subjects
Sources
@Reuters
Roche, Eli Lilly's Alzheimer's blood test gets FDA clearance https://t.co/JIPCdbzkmr https://t.co/JIPCdbzkmr
@blckchaindaily
🚨 FDA CLEARS ROCHE AND ELI LILLY'S ALZHEIMER'S BLOOD TEST
@WSJ
The Food and Drug Administration cleared a blood test for identifying Alzheimer’s disease symptoms, which was developed by Roche and Eli Lilly. https://t.co/rYp0au5rDE